-
PGC-1 Alpha as a Neuroprotective Target in Parkinson’s Disease
… a viable target? Bauer Forum. June 29, 2011. FAS Center for Systems Biology. Harvard University. Cambridge. …
-
Global Parkinson’s Genetics Program (GP2)
… of Lubeck, Germany Rejko Kruger, MD; Luxembourg Centre for Systems Biomedicine, Luxembourg Ken Marek, MD; The Michael …
-
The Michael J. Fox Foundation for Parkinson’s Research Announces New Chairman of the Board, Biopharma Leader Skip Irving
February 27, 2020
… class of therapeutics for the treatment of central nervous system disorders. He sits on the Board of Overseers for …
-
News in Context: New Drug Approved for Alzheimer’s Disease “Is a Real Signal to Research and Patient Communities”
June 10, 2021
… biomarkers of alpha-synuclein, as well as other biological systems linked to Parkinson’s disease. Of note, the …
-
What We Fund: $30M Toward Innovative Parkinson’s Diagnostic Tools and Disease Modifying Therapies
December 16, 2022
… and further development are needed to improve the system and to obtain approval for clinical use. Disease …
-
What We Fund: $28M toward Therapies to Stop Disease, a Test for Voice Changes and a Genetic Profiling Study Using Stem Cells
April 20, 2022
… of programs and technologies that aim to improve this system. The study also includes people who are at risk for …
Animations
Your search for “Multiple System Atrophy” returned 2623 results.